Among breast cancer subtypes, the median TMB was higher in patients with triple-negative breast cancer (4.60 muts/Mb) compared to hormone receptor-positive patients (3.10 muts/Mb) [40]. This evidence concerns the gene NR4A1 and triple-negative breast carcinoma.